Mergers & Acquisitions - Licensing, Regulation

Filter

Current filters:

LicensingRegulation

Popular Filters

Teva invests $7.5 million in Cocrystal Discovery for novel hepatitis C antiviral

18-09-2011

In a further move to boost its non-generics activities, Israel’s Teva Pharmaceutical Industries…

Anti-viralsCocrystal DiscoveryLicensingMergers & AcquisitionsPharmaceuticalRegulationTeva Pharmaceutical Industries

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top